Founded in 1986, BioCryst has over 80 employees spread across our two locations in Birmingham, Alabama and Durham, North Carolina. With expertise in drug discovery, clinical development and regulatory affairs, we continue to advance our compounds, peramivir, forodesine and BCX4208, and to generate new compounds from our own discovery engine—structure-based drug design.

We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives.

The commitment of BioCryst has remained unchanged.  We continue to be passionate about advancing novel therapeutics for patients with serious diseases.